RBC Capital Markets analyst Bish Koziol made eight changes to his quantitatively driven top 40 list of stock picks. Maple ...
RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report) yesterday and set a price ...
Acknowledging that there is skepticism surrounding its business model and ability to sustain profitability targets, RBC Capital joins the growing list of bulls in support of Carvana, raising its ...
RBC Capital analyst Brian Abrahams says shares of Sarepta (SRPT) could be trading lower today on an FDA database update that ...
analysts at RBC Capital Markets said. The tweak to the required acceptance threshold for the bid, which now excludes shares held in treasury with no voting rights, came “at the request of the ...
The strategic pivot to investment banking in the U.S., which coincided with pulling out of an unsuccessful and capital-intensive foray into the ultra-competitive and regulation-heavy retail banking ...
The downgrade comes after the company reported full-year revenue that fell 4% below market expectations, reflecting an underperformance in the second half of the year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results